NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 74 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.28 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $17,000 | +88.9% | 125,482 | +51.6% | 0.00% | – |
| Q4 2018 | $9,000 | -50.0% | 82,761 | +5.5% | 0.00% | – |
| Q3 2018 | $18,000 | +38.5% | 78,474 | +37.1% | 0.00% | – |
| Q2 2018 | $13,000 | -23.5% | 57,246 | +21.3% | 0.00% | – |
| Q1 2018 | $17,000 | -64.6% | 47,213 | -65.2% | 0.00% | – |
| Q4 2017 | $48,000 | -52.9% | 135,769 | -44.5% | 0.00% | – |
| Q3 2017 | $102,000 | +684.6% | 244,430 | +917.8% | 0.00% | – |
| Q2 2017 | $13,000 | +116.7% | 24,016 | +118.3% | 0.00% | – |
| Q1 2017 | $6,000 | -92.0% | 11,000 | -90.6% | 0.00% | – |
| Q4 2016 | $75,000 | +134.4% | 117,225 | +230.7% | 0.00% | – |
| Q3 2016 | $32,000 | -53.6% | 35,450 | -72.6% | 0.00% | – |
| Q2 2016 | $69,000 | -96.7% | 129,333 | -94.1% | 0.00% | -100.0% |
| Q1 2016 | $2,078,000 | -33.9% | 2,199,033 | -7.0% | 0.00% | -50.0% |
| Q4 2015 | $3,145,000 | -42.0% | 2,364,922 | -0.6% | 0.00% | -50.0% |
| Q3 2015 | $5,426,000 | +75.8% | 2,379,688 | +24.1% | 0.00% | +100.0% |
| Q2 2015 | $3,087,000 | +22.3% | 1,917,029 | +20.8% | 0.00% | 0.0% |
| Q1 2015 | $2,524,000 | +120.4% | 1,587,378 | +162.2% | 0.00% | +100.0% |
| Q4 2014 | $1,145,000 | – | 605,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|